BFR: Blood Flow Restriction Following ACL Reconstruction

Sponsor
Inova Health Care Services (Other)
Overall Status
Recruiting
CT.gov ID
NCT03758755
Collaborator
(none)
60
1
2
48
1.3

Study Details

Study Description

Brief Summary

The main objective is to determine the impact of Blood Flow Restriction (BFR) therapy, in comparison to a standard rehabilitation protocol, on preventing atrophy, improving quadriceps strength and improving functional outcomes of patients recovering from ACL reconstruction. The investigators hypothesize that patients undergoing BFR therapy after ACL reconstruction surgery will have better functional outcomes than those undergoing normal rehabilitation without BFR therapy.

Condition or Disease Intervention/Treatment Phase
  • Device: Blood Flow Restriction Therapy
  • Other: ACL Reconstruction rehabilitation
N/A

Detailed Description

Recovery from anterior cruciate ligament (ACL) reconstruction involves early physical therapy to promote muscular development. Traditional training regimens are based on the concept that muscle growth is induced with high resistance exercises of at least 65-70% of 1-repetition maximum. Achieving a high resistance level can be challenging in the early post-surgical patient who may be limited by pain, muscle atrophy, diminished proprioception, and psychological factors. Increasing evidence has suggested that Blood Flow Restriction (BFR) in resistance training, while transmitting a decreased load (25-50% of 1-repetition maximum) across the surgical site, may provide an additional benefit of inducing muscular development similar to that of high intensity exercises .

Augmenting exercises with BFR involves an external pressure cuff applied to the proximal portion of the extremity, which is inflated to a pressure that restricts venous outflow while allowing arterial inflow to continue. This creates a physiologic environment for the patient to gain the hypertrophic effect of high resistance training, though at a lower and safer intensity. Studies suggest that BFR stimulates muscular development through an increase in metabolic stress, muscle fiber recruitment, cell swelling, and protein synthesis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Blood Flow Restriction Therapy Following Anterior Cruciate Ligament Reconstruction
Actual Study Start Date :
Nov 1, 2018
Actual Primary Completion Date :
Nov 1, 2021
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: BFR Therapy

This group will undergo physical therapy exercises per the standard of care, with the addition of Blood Flow Restriction (BFR) utilizing a wide pressure cuff. BFR exercises will be initiated two weeks post-op, and continued for 16 weeks.

Device: Blood Flow Restriction Therapy
A wide pressure cuff will be applied to the upper thigh prior to starting strengthening exercises. The cuff is inflated to 80% of resting systolic blood pressure. The cuff remains inflated for the entirety of the exercise (4 sets of a specific movement). Once the exercises are completed, it is deflated for a minimum of one minute before the next type of exercises are started.

Other: ACL Reconstruction rehabilitation
post-operative rehabilitation according to current standards of care

Active Comparator: No BFR

This group of patients will undergo physical therapy exercises per the current standard of care after their ACL reconstruction without BFR

Other: ACL Reconstruction rehabilitation
post-operative rehabilitation according to current standards of care

Outcome Measures

Primary Outcome Measures

  1. International Knee Documentation Committee (IKDC) [Measured at 3, 6, 12, 24 months post op]

    The International Knee Documentation Committee (IKDC Questionnaire) is a knee-specific patient-reported outcome measure. The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.

  2. Visual Analog Score [Measured at 2,4,6,12 weeks and 6, 12, and 24 months post op]

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."

  3. Quadriceps Tendon Strength [Measured weekly up to 16 weeks and then at 6 months.]

    We will measure quadriceps tendon strength (closed chain) strength using a dynamometer.

  4. Thigh Circumference [Measured weekly up to 16 weeks and then at 6 months.]

    A tape measure will be used to measure the thigh circumference 15 cm proximal to the superior pole of the patella

Secondary Outcome Measures

  1. Adverse Effects [Tracked from initiation of therapy 2 weeks post-op through 16 weeks post-op]

    Observation of any adverse events associated with BFR therapy, such as numbness, cuff-site pain, and bruising.

Eligibility Criteria

Criteria

Ages Eligible for Study:
13 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 13-35 years at the time of surgery

  2. ACL reconstruction

  3. Using a physical therapy center with Blood Flow Restriction capabilities.

Exclusion Criteria:
  1. Concomitant ligament reconstruction

  2. Concurrent procedures that require delayed weight bearing (ie: HTO, multiligament reconstruction, microfracture, etc)

  3. History of DVT/PE

  4. Immunocompromising conditions (ie: Rheumatoid arthritis, chronic steroid use, etc.)

  5. History of coagulation disorders or current use of anticoagulants

  6. Completion of physical therapy at a location not affiliated with the study

  7. Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Inova Health System Fairfax Virginia United States 22031

Sponsors and Collaborators

  • Inova Health Care Services

Investigators

  • Principal Investigator: Edward Chang, MD, Orthopedic Surgeon

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Edward Chang, MD, Orthopedic Surgeon, Inova Health Care Services
ClinicalTrials.gov Identifier:
NCT03758755
Other Study ID Numbers:
  • 18-3150
First Posted:
Nov 29, 2018
Last Update Posted:
Feb 15, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Edward Chang, MD, Orthopedic Surgeon, Inova Health Care Services
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2022